COVID-19 Causes Further Delay To Canada’s Controversial Pricing Reforms

 
• By Francesca Bruce
  
Delays
Industry Welcomes Delays To Canadian Drug Pricing Reforms • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Canada

More from North America